Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jibe Therapeutics is developing a next-generation cancer immunotherapy platform that uses universal T-cell engagers to connect a patient’s naturally occurring tumor-targeting antibodies to their own T-cells, enhancing immune recognition and attack of tumors. The company is in preclinical development and has recently won the American Cancer Society’s BrightEdge Golden Ticket Pitch Competition, which will support its research operations relocation to Dallas and provide access to industry mentorship and resources.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jibe.